论文部分内容阅读
目的:对应用孟鲁司特钠与阿奇霉素联合对患有支原体肺炎疾病的患儿实施治疗的临床效果进行研究。方法:将我院收治的84例患有支原体肺炎疾病的患儿随机分为对照组和治疗组,平均每组42例。采用单纯应用阿奇霉素对对照组患儿实施治疗;采用孟鲁司特钠与阿奇霉素联合对治疗组患儿实施治疗。结果:治疗组患儿支原体肺炎疾病控制效果明显优于对照组;肺部功能指标水平恢复正常时间和接受药物治疗总时间明显短于对照组。结论:应用孟鲁司特钠与阿奇霉素联合对患有支原体肺炎疾病的患儿实施治疗的临床效果非常明显。
OBJECTIVE: To study the clinical effect of montelukast sodium combined with azithromycin in the treatment of children with mycoplasma pneumonia. Methods: 84 cases of mycoplasma pneumonia admitted to our hospital were randomly divided into control group and treatment group, with an average of 42 cases in each group. Adopting pure azithromycin to treat children in the control group. The patients in the treatment group were treated with montelukast sodium and azithromycin. Results: The control effect of mycoplasma pneumonia in the treatment group was significantly better than that of the control group. The time of recovering the normal level of lung function index and the time of receiving the medication were obviously shorter than those of the control group. Conclusions: The clinical effect of montelukast sodium and azithromycin in the treatment of children with mycoplasma pneumonia is very obvious.